The global LNP-mRNA Therapy market was valued at US$ 553 million in 2025 and is anticipated to reach US$ 805 million by 2032, at a CAGR of 5.6% from 2026 to 2032.

LNP-mRNA Therapy Market

LNP-mRNA Therapy represents a cutting-edge biomedical technology that leverages the unique strengths of Lipid Nanoparticles (LNPs) and Messenger RNA (mRNA) to offer novel treatment avenues for various diseases. Serving as carriers, LNPs effectively shield mRNA from enzymatic degradation in the body and deliver it precisely to target cells. mRNA carries the genetic information necessary for synthesizing specific proteins; once inside cells, it directs the cells to produce these proteins, thereby triggering immune responses or repairing damaged tissues. This therapy demonstrates significant potential in treating cancers, genetic disorders, and infectious diseases. Its highly personalized and rapid-response characteristics have made LNP-mRNA Therapy a research focus in the biomedical field. By precisely regulating gene expression, LNP-mRNA Therapy provides patients with unprecedented treatment options, ushering in a new era of precision medicine.

The LNP-mRNA Therapy market is in a phase of rapid development. Following the successful application of COVID-19 vaccines, global R&D focus has expanded to areas such as cancer immunotherapy, rare genetic diseases, cardiovascular diseases, and regenerative medicine. With the optimization of intelligent delivery systems and the maturation of production processes, the market size is expected to maintain high growth over the next decade, driven by the needs of infectious disease control, large-scale data center-based vaccine production capabilities, investment in new energy medical technologies, and the trend towards precision medicine. Despite challenges such as cost, stability, and regulation, with policy support and capital investment in North America, Europe, and the Asia-Pacific region, LNP-mRNA technology is poised to become a core platform for next-generation biomedicine, driving the upgrading of the global pharmaceutical industry structure.

This report delivers a comprehensive overview of the global LNP-mRNA Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding LNP-mRNA Therapy. The LNP-mRNA Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global LNP-mRNA Therapy market comprehensively. Regional market sizes by Type, by Application, by Treatment Direction, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist LNP-mRNA Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of LNP-mRNA Therapy Market Report

Report Metric	Details
Report Name	LNP-mRNA Therapy Market
Accounted market size in 2025	US$ 553 million
Forecasted market size in 2032	US$ 805 million
CAGR	5.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Passive Targeting Active Targeting
Segment by Treatment Direction	Vaccines Cancer Immunotherapy Genetic Disease Therapy Others
Segment by Mechanisms of Action	Protein Replacement Therapy Immune Activation Therapy Gene Regulation Therapy
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Genevant Sciences, Moderna, BioNTech, Pfizer, NanoVation Therapeutics, CureVac, Sanofi, Promab, Grand Pharm, Arcturus Therapeutics, Synplogen, CSPC, Beijing JenKem Technology, Starna Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Treatment Direction, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for LNP-mRNA Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is LNP-mRNA Therapy Market growing?

Ans: The LNP-mRNA Therapy Market witnessing a CAGR of 5.6% during the forecast period 2026-2032.

What is the LNP-mRNA Therapy Market size in 2032?

Ans: The LNP-mRNA Therapy Market size in 2032 will be US$ 805 million.

Who are the main players in the LNP-mRNA Therapy Market report?

Ans: The main players in the LNP-mRNA Therapy Market are Genevant Sciences, Moderna, BioNTech, Pfizer, NanoVation Therapeutics, CureVac, Sanofi, Promab, Grand Pharm, Arcturus Therapeutics, Synplogen, CSPC, Beijing JenKem Technology, Starna Therapeutics

What are the Application segmentation covered in the LNP-mRNA Therapy Market report?

Ans: The Applications covered in the LNP-mRNA Therapy Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the LNP-mRNA Therapy Market report?

Ans: The Types covered in the LNP-mRNA Therapy Market report are Passive Targeting, Active Targeting

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global LNP-mRNA Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Passive Targeting

1.2.3 Active Targeting

1.3 Market by Treatment Direction

1.3.1 Global LNP-mRNA Therapy Market Size Growth Rate by Treatment Direction: 2021 vs 2025 vs 2032

1.3.2 Vaccines

1.3.3 Cancer Immunotherapy

1.3.4 Genetic Disease Therapy

1.3.5 Others

1.4 Market by Mechanisms of Action

1.4.1 Global LNP-mRNA Therapy Market Size Growth Rate by Mechanisms of Action: 2021 vs 2025 vs 2032

1.4.2 Protein Replacement Therapy

1.4.3 Immune Activation Therapy

1.4.4 Gene Regulation Therapy

1.5 Market by Application

1.5.1 Global LNP-mRNA Therapy Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Hospital

1.5.3 Clinic

1.5.4 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global LNP-mRNA Therapy Market Perspective (2021–2032)

2.2 Global LNP-mRNA Therapy Growth Trends by Region

2.2.1 Global LNP-mRNA Therapy Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 LNP-mRNA Therapy Historic Market Size by Region (2021–2026)

2.2.3 LNP-mRNA Therapy Forecasted Market Size by Region (2027–2032)

2.3 LNP-mRNA Therapy Market Dynamics

2.3.1 LNP-mRNA Therapy Industry Trends

2.3.2 LNP-mRNA Therapy Market Drivers

2.3.3 LNP-mRNA Therapy Market Challenges

2.3.4 LNP-mRNA Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top LNP-mRNA Therapy Players by Revenue

3.1.1 Global Top LNP-mRNA Therapy Players by Revenue (2021–2026)

3.1.2 Global LNP-mRNA Therapy Revenue Market Share by Players (2021–2026)

3.2 Global Top LNP-mRNA Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by LNP-mRNA Therapy Revenue

3.4 Global LNP-mRNA Therapy Market Concentration Ratio

3.4.1 Global LNP-mRNA Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by LNP-mRNA Therapy Revenue in 2025

3.5 Global Key Players of LNP-mRNA Therapy Head Offices and Areas Served

3.6 Global Key Players of LNP-mRNA Therapy, Products and Applications

3.7 Global Key Players of LNP-mRNA Therapy, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 LNP-mRNA Therapy Breakdown Data by Type

4.1 Global LNP-mRNA Therapy Historic Market Size by Type (2021–2026)

4.2 Global LNP-mRNA Therapy Forecasted Market Size by Type (2027–2032)

5 LNP-mRNA Therapy Breakdown Data by Application

5.1 Global LNP-mRNA Therapy Historic Market Size by Application (2021–2026)

5.2 Global LNP-mRNA Therapy Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America LNP-mRNA Therapy Market Size (2021–2032)

6.2 North America LNP-mRNA Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America LNP-mRNA Therapy Market Size by Country (2021–2026)

6.4 North America LNP-mRNA Therapy Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe LNP-mRNA Therapy Market Size (2021–2032)

7.2 Europe LNP-mRNA Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe LNP-mRNA Therapy Market Size by Country (2021–2026)

7.4 Europe LNP-mRNA Therapy Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific LNP-mRNA Therapy Market Size (2021–2032)

8.2 Asia-Pacific LNP-mRNA Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific LNP-mRNA Therapy Market Size by Region (2021–2026)

8.4 Asia-Pacific LNP-mRNA Therapy Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America LNP-mRNA Therapy Market Size (2021–2032)

9.2 Latin America LNP-mRNA Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America LNP-mRNA Therapy Market Size by Country (2021–2026)

9.4 Latin America LNP-mRNA Therapy Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa LNP-mRNA Therapy Market Size (2021–2032)

10.2 Middle East & Africa LNP-mRNA Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa LNP-mRNA Therapy Market Size by Country (2021–2026)

10.4 Middle East & Africa LNP-mRNA Therapy Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Genevant Sciences

11.1.1 Genevant Sciences Company Details

11.1.2 Genevant Sciences Business Overview

11.1.3 Genevant Sciences LNP-mRNA Therapy Introduction

11.1.4 Genevant Sciences Revenue in LNP-mRNA Therapy Business (2021–2026)

11.1.5 Genevant Sciences Recent Development

11.2 Moderna

11.2.1 Moderna Company Details

11.2.2 Moderna Business Overview

11.2.3 Moderna LNP-mRNA Therapy Introduction

11.2.4 Moderna Revenue in LNP-mRNA Therapy Business (2021–2026)

11.2.5 Moderna Recent Development

11.3 BioNTech

11.3.1 BioNTech Company Details

11.3.2 BioNTech Business Overview

11.3.3 BioNTech LNP-mRNA Therapy Introduction

11.3.4 BioNTech Revenue in LNP-mRNA Therapy Business (2021–2026)

11.3.5 BioNTech Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer LNP-mRNA Therapy Introduction

11.4.4 Pfizer Revenue in LNP-mRNA Therapy Business (2021–2026)

11.4.5 Pfizer Recent Development

11.5 NanoVation Therapeutics

11.5.1 NanoVation Therapeutics Company Details

11.5.2 NanoVation Therapeutics Business Overview

11.5.3 NanoVation Therapeutics LNP-mRNA Therapy Introduction

11.5.4 NanoVation Therapeutics Revenue in LNP-mRNA Therapy Business (2021–2026)

11.5.5 NanoVation Therapeutics Recent Development

11.6 CureVac

11.6.1 CureVac Company Details

11.6.2 CureVac Business Overview

11.6.3 CureVac LNP-mRNA Therapy Introduction

11.6.4 CureVac Revenue in LNP-mRNA Therapy Business (2021–2026)

11.6.5 CureVac Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Details

11.7.2 Sanofi Business Overview

11.7.3 Sanofi LNP-mRNA Therapy Introduction

11.7.4 Sanofi Revenue in LNP-mRNA Therapy Business (2021–2026)

11.7.5 Sanofi Recent Development

11.8 Promab

11.8.1 Promab Company Details

11.8.2 Promab Business Overview

11.8.3 Promab LNP-mRNA Therapy Introduction

11.8.4 Promab Revenue in LNP-mRNA Therapy Business (2021–2026)

11.8.5 Promab Recent Development

11.9 Grand Pharm

11.9.1 Grand Pharm Company Details

11.9.2 Grand Pharm Business Overview

11.9.3 Grand Pharm LNP-mRNA Therapy Introduction

11.9.4 Grand Pharm Revenue in LNP-mRNA Therapy Business (2021–2026)

11.9.5 Grand Pharm Recent Development

11.10 Arcturus Therapeutics

11.10.1 Arcturus Therapeutics Company Details

11.10.2 Arcturus Therapeutics Business Overview

11.10.3 Arcturus Therapeutics LNP-mRNA Therapy Introduction

11.10.4 Arcturus Therapeutics Revenue in LNP-mRNA Therapy Business (2021–2026)

11.10.5 Arcturus Therapeutics Recent Development

11.11 Synplogen

11.11.1 Synplogen Company Details

11.11.2 Synplogen Business Overview

11.11.3 Synplogen LNP-mRNA Therapy Introduction

11.11.4 Synplogen Revenue in LNP-mRNA Therapy Business (2021–2026)

11.11.5 Synplogen Recent Development

11.12 CSPC

11.12.1 CSPC Company Details

11.12.2 CSPC Business Overview

11.12.3 CSPC LNP-mRNA Therapy Introduction

11.12.4 CSPC Revenue in LNP-mRNA Therapy Business (2021–2026)

11.12.5 CSPC Recent Development

11.13 Beijing JenKem Technology

11.13.1 Beijing JenKem Technology Company Details

11.13.2 Beijing JenKem Technology Business Overview

11.13.3 Beijing JenKem Technology LNP-mRNA Therapy Introduction

11.13.4 Beijing JenKem Technology Revenue in LNP-mRNA Therapy Business (2021–2026)

11.13.5 Beijing JenKem Technology Recent Development

11.14 Starna Therapeutics

11.14.1 Starna Therapeutics Company Details

11.14.2 Starna Therapeutics Business Overview

11.14.3 Starna Therapeutics LNP-mRNA Therapy Introduction

11.14.4 Starna Therapeutics Revenue in LNP-mRNA Therapy Business (2021–2026)

11.14.5 Starna Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

NanoVation Therapeutics

Arcturus Therapeutics

CSPC

Beijing Jenkem Technology

Starna Therapeutics

Synplogen

List of Tables

Table 1. Global LNP-mRNA Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Passive Targeting

Table 3. Key Players of Active Targeting

Table 4. Global LNP-mRNA Therapy Market Size Growth Rate by Treatment Direction (US$ Million): 2021 vs 2025 vs 2032

Table 5. Key Players of Vaccines

Table 6. Key Players of Cancer Immunotherapy

Table 7. Key Players of Genetic Disease Therapy

Table 8. Key Players of Others

Table 9. Global LNP-mRNA Therapy Market Size Growth Rate by Mechanisms of Action (US$ Million): 2021 vs 2025 vs 2032

Table 10. Key Players of Protein Replacement Therapy

Table 11. Key Players of Immune Activation Therapy

Table 12. Key Players of Gene Regulation Therapy

Table 13. Global LNP-mRNA Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 14. Global LNP-mRNA Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 15. Global LNP-mRNA Therapy Market Size by Region (US$ Million), 2021–2026

Table 16. Global LNP-mRNA Therapy Market Share by Region (2021–2026)

Table 17. Global LNP-mRNA Therapy Forecasted Market Size by Region (US$ Million), 2027–2032

Table 18. Global LNP-mRNA Therapy Market Share by Region (2027–2032)

Table 19. LNP-mRNA Therapy Market Trends

Table 20. LNP-mRNA Therapy Market Drivers

Table 21. LNP-mRNA Therapy Market Challenges

Table 22. LNP-mRNA Therapy Market Restraints

Table 23. Global LNP-mRNA Therapy Revenue by Players (US$ Million), 2021–2026

Table 24. Global LNP-mRNA Therapy Market Share by Players (2021–2026)

Table 25. Global Top LNP-mRNA Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on LNP-mRNA Therapy Revenue, 2025

Table 26. Ranking of Global Top LNP-mRNA Therapy Companies by Revenue (US$ Million) in 2025

Table 27. Global 5 Largest Players Market Share by LNP-mRNA Therapy Revenue (CR5 and HHI), 2021–2026

Table 28. Global Key Players of LNP-mRNA Therapy, Headquarters and Area Served

Table 29. Global Key Players of LNP-mRNA Therapy, Products and Applications

Table 30. Global Key Players of LNP-mRNA Therapy, Date of General Availability (GA)

Table 31. Mergers and Acquisitions, Expansion Plans

Table 32. Global LNP-mRNA Therapy Market Size by Type (US$ Million), 2021–2026

Table 33. Global LNP-mRNA Therapy Revenue Market Share by Type (2021–2026)

Table 34. Global LNP-mRNA Therapy Forecasted Market Size by Type (US$ Million), 2027–2032

Table 35. Global LNP-mRNA Therapy Revenue Market Share by Type (2027–2032)

Table 36. Global LNP-mRNA Therapy Market Size by Application (US$ Million), 2021–2026

Table 37. Global LNP-mRNA Therapy Revenue Market Share by Application (2021–2026)

Table 38. Global LNP-mRNA Therapy Forecasted Market Size by Application (US$ Million), 2027–2032

Table 39. Global LNP-mRNA Therapy Revenue Market Share by Application (2027–2032)

Table 40. North America LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. North America LNP-mRNA Therapy Market Size by Country (US$ Million), 2021–2026

Table 42. North America LNP-mRNA Therapy Market Size by Country (US$ Million), 2027–2032

Table 43. Europe LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Europe LNP-mRNA Therapy Market Size by Country (US$ Million), 2021–2026

Table 45. Europe LNP-mRNA Therapy Market Size by Country (US$ Million), 2027–2032

Table 46. Asia-Pacific LNP-mRNA Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 47. Asia-Pacific LNP-mRNA Therapy Market Size by Region (US$ Million), 2021–2026

Table 48. Asia-Pacific LNP-mRNA Therapy Market Size by Region (US$ Million), 2027–2032

Table 49. Latin America LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 50. Latin America LNP-mRNA Therapy Market Size by Country (US$ Million), 2021–2026

Table 51. Latin America LNP-mRNA Therapy Market Size by Country (US$ Million), 2027–2032

Table 52. Middle East & Africa LNP-mRNA Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 53. Middle East & Africa LNP-mRNA Therapy Market Size by Country (US$ Million), 2021–2026

Table 54. Middle East & Africa LNP-mRNA Therapy Market Size by Country (US$ Million), 2027–2032

Table 55. Genevant Sciences Company Details

Table 56. Genevant Sciences Business Overview

Table 57. Genevant Sciences LNP-mRNA Therapy Product

Table 58. Genevant Sciences Revenue in LNP-mRNA Therapy Business (US$ Million), 2021–2026

Table 59. Genevant Sciences Recent Development

Table 60. Moderna Company Details

Table 61. Moderna Business Overview

Table 62. Moderna LNP-mRNA Therapy Product

Table 63. Moderna Revenue in LNP-mRNA Therapy Business (US$ Million), 2021–2026

Table 64. Moderna Recent Development

Table 65. BioNTech Company Details

Table 66. BioNTech Business Overview

Table 67. BioNTech LNP-mRNA Therapy Product

Table 68. BioNTech Revenue in LNP-mRNA Therapy Business (US$ Million), 2021–2026

Table 69. BioNTech Recent Development

Table 70. Pfizer Company Details

Table 71. Pfizer Business Overview

Table 72. Pfizer LNP-mRNA Therapy Product

Table 73. Pfizer Revenue in LNP-mRNA Therapy Business (US$ Million), 2021–2026

Table 74. Pfizer Recent Development

Table 75. NanoVation Therapeutics Company Details

Table 76. NanoVation Therapeutics Business Overview

Table 77. NanoVation Therapeutics LNP-mRNA Therapy Product

Table 78. NanoVation Therapeutics Revenue in LNP-mRNA Therapy Business (US$ Million), 2021–2026

Table 79. NanoVation Therapeutics Recent Development

Table 80. CureVac Company Details

Table 81. CureVac Business Overview

Table 82. CureVac LNP-mRNA Therapy Product

Table 83. CureVac Revenue in LNP-mRNA Therapy Business (US$ Million), 2021–2026

Table 84. CureVac Recent Development

Table 85. Sanofi Company Details

Table 86. Sanofi Business Overview

Table 87. Sanofi LNP-mRNA Therapy Product

Table 88. Sanofi Revenue in LNP-mRNA Therapy Business (US$ Million), 2021–2026

Table 89. Sanofi Recent Development

Table 90. Promab Company Details

Table 91. Promab Business Overview

Table 92. Promab LNP-mRNA Therapy Product

Table 93. Promab Revenue in LNP-mRNA Therapy Business (US$ Million), 2021–2026

Table 94. Promab Recent Development

Table 95. Grand Pharm Company Details

Table 96. Grand Pharm Business Overview

Table 97. Grand Pharm LNP-mRNA Therapy Product

Table 98. Grand Pharm Revenue in LNP-mRNA Therapy Business (US$ Million), 2021–2026

Table 99. Grand Pharm Recent Development

Table 100. Arcturus Therapeutics Company Details

Table 101. Arcturus Therapeutics Business Overview

Table 102. Arcturus Therapeutics LNP-mRNA Therapy Product

Table 103. Arcturus Therapeutics Revenue in LNP-mRNA Therapy Business (US$ Million), 2021–2026

Table 104. Arcturus Therapeutics Recent Development

Table 105. Synplogen Company Details

Table 106. Synplogen Business Overview

Table 107. Synplogen LNP-mRNA Therapy Product

Table 108. Synplogen Revenue in LNP-mRNA Therapy Business (US$ Million), 2021–2026

Table 109. Synplogen Recent Development

Table 110. CSPC Company Details

Table 111. CSPC Business Overview

Table 112. CSPC LNP-mRNA Therapy Product

Table 113. CSPC Revenue in LNP-mRNA Therapy Business (US$ Million), 2021–2026

Table 114. CSPC Recent Development

Table 115. Beijing JenKem Technology Company Details

Table 116. Beijing JenKem Technology Business Overview

Table 117. Beijing JenKem Technology LNP-mRNA Therapy Product

Table 118. Beijing JenKem Technology Revenue in LNP-mRNA Therapy Business (US$ Million), 2021–2026

Table 119. Beijing JenKem Technology Recent Development

Table 120. Starna Therapeutics Company Details

Table 121. Starna Therapeutics Business Overview

Table 122. Starna Therapeutics LNP-mRNA Therapy Product

Table 123. Starna Therapeutics Revenue in LNP-mRNA Therapy Business (US$ Million), 2021–2026

Table 124. Starna Therapeutics Recent Development

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

Table 128. Authors List of This Report

List of Figures

Figure 1. LNP-mRNA Therapy Picture

Figure 2. Global LNP-mRNA Therapy Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global LNP-mRNA Therapy Market Share by Type: 2025 vs 2032

Figure 4. Passive Targeting Features

Figure 5. Active Targeting Features

Figure 6. Global LNP-mRNA Therapy Market Size Comparison by Treatment Direction (US$ Million), 2021–2032

Figure 7. Vaccines Features

Figure 8. Cancer Immunotherapy Features

Figure 9. Genetic Disease Therapy Features

Figure 10. Others Features

Figure 11. Global LNP-mRNA Therapy Market Size Comparison by Mechanisms of Action (US$ Million), 2021–2032

Figure 12. Protein Replacement Therapy Features

Figure 13. Immune Activation Therapy Features

Figure 14. Gene Regulation Therapy Features

Figure 15. Global LNP-mRNA Therapy Market Size by Application (US$ Million), 2021–2032

Figure 16. Global LNP-mRNA Therapy Market Share by Application: 2025 vs 2032

Figure 17. Hospital Case Studies

Figure 18. Clinic Case Studies

Figure 19. Others Case Studies

Figure 20. LNP-mRNA Therapy Report Years Considered

Figure 21. Global LNP-mRNA Therapy Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 22. Global LNP-mRNA Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global LNP-mRNA Therapy Market Share by Region: 2025 vs 2032

Figure 24. Global LNP-mRNA Therapy Market Share by Players in 2025

Figure 25. Global LNP-mRNA Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 26. The Top 10 and 5 Players Market Share by LNP-mRNA Therapy Revenue in 2025

Figure 27. North America LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. North America LNP-mRNA Therapy Market Share by Country (2021–2032)

Figure 29. United States LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Canada LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Europe LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Europe LNP-mRNA Therapy Market Share by Country (2021–2032)

Figure 33. Germany LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. France LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. U.K. LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Italy LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Russia LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Ireland LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Asia-Pacific LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Asia-Pacific LNP-mRNA Therapy Market Share by Region (2021–2032)

Figure 41. China LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Japan LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. South Korea LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Southeast Asia LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. India LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Australia & New Zealand LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Latin America LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Latin America LNP-mRNA Therapy Market Share by Country (2021–2032)

Figure 49. Mexico LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Brazil LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Middle East & Africa LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Middle East & Africa LNP-mRNA Therapy Market Share by Country (2021–2032)

Figure 53. Israel LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Saudi Arabia LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. UAE LNP-mRNA Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Genevant Sciences Revenue Growth Rate in LNP-mRNA Therapy Business (2021–2026)

Figure 57. Moderna Revenue Growth Rate in LNP-mRNA Therapy Business (2021–2026)

Figure 58. BioNTech Revenue Growth Rate in LNP-mRNA Therapy Business (2021–2026)

Figure 59. Pfizer Revenue Growth Rate in LNP-mRNA Therapy Business (2021–2026)

Figure 60. NanoVation Therapeutics Revenue Growth Rate in LNP-mRNA Therapy Business (2021–2026)

Figure 61. CureVac Revenue Growth Rate in LNP-mRNA Therapy Business (2021–2026)

Figure 62. Sanofi Revenue Growth Rate in LNP-mRNA Therapy Business (2021–2026)

Figure 63. Promab Revenue Growth Rate in LNP-mRNA Therapy Business (2021–2026)

Figure 64. Grand Pharm Revenue Growth Rate in LNP-mRNA Therapy Business (2021–2026)

Figure 65. Arcturus Therapeutics Revenue Growth Rate in LNP-mRNA Therapy Business (2021–2026)

Figure 66. Synplogen Revenue Growth Rate in LNP-mRNA Therapy Business (2021–2026)

Figure 67. CSPC Revenue Growth Rate in LNP-mRNA Therapy Business (2021–2026)

Figure 68. Beijing JenKem Technology Revenue Growth Rate in LNP-mRNA Therapy Business (2021–2026)

Figure 69. Starna Therapeutics Revenue Growth Rate in LNP-mRNA Therapy Business (2021–2026)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Lipid Nanoparticle LNP Production Equipment Market Research Report 2024

Global Lipid Nanoparticle LNP Formulation Service Market Research Report 2025

Global Lipid Nanoparticle LNP Formulation Market Research Report 2024

Global mRNA Delivery System Market Research Report 2024

Global Lipid Nanoparticle LNP Synthesis Services Market Research Report 2025

Global Lipid Nanoparticle LNP Development Service Market Research Report 2025

Global Lipid Nanoparticles LNP Market Research Report 2024

Global Lipid Nanoparticle LNP Services Market Research Report 2025

Global RNA LNP Lipid Nanoparticle Formulation Market Research Report 2024

Global mRNA Vaccines Therapeutics Market Research Report 2024

Global mRNA Therapy Market Research Report 2024

Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030

Global Lipid Nanoparticle LNP Raw Material Market Research Report 2024

Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030

Global mRNA Treatment Market Research Report 2024

Global Lipid Nanoparticle CDMO Market Research Report 2025

Global Personalized mRNA Cancer Vaccine Therapy Market Research Report 2025

Global Lipid Contract Manufacturing Market Research Report 2024

Global Nanoparticle Drug Delivery Systems Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions